Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.

Tissue-to-plasma water partition coefficients (Kpu's) form an integral part of whole body physiologically based pharmacokinetic (WBPBPK) models. This research aims to improve the predictability of Kpu values for moderate-to-strong bases (pK(a) > or = 7), by developing a mechanistic equation that accommodates the unique electrostatic interactions of such drugs with tissue acidic phospholipids, where the affinity of this interaction is readily estimated from drug blood cell binding data. Additional model constituents are drug partitioning into neutral lipids and neutral phospholipids, and drug dissolution in tissue water. Major assumptions of this equation are that electrostatic interactions predominate, drugs distribute passively, and non-saturating conditions prevail. Resultant Kpu predictions for 28 moderate-to-strong bases were significantly more accurate than published equations with 89%, compared to 45%, of the predictions being within a factor of three of experimental values in rat adipose, bone, gut, heart, kidney, liver, muscle, pancreas, skin, spleen and thymus. Predictions in rat brain and lung were less accurate probably due to the involvement of additional processes not incorporated within the equation. This overall improvement in prediction should facilitate the further application of WBPBPK modeling, where time, cost and labor requirements associated with experimentally determining Kpu's have, to a large extent, deterred its application.

[1]  G. Nelson,et al.  Lipid composition of erythrocytes in various mammalian species. , 1967, Biochimica et biophysica acta.

[2]  D. Garteiz Metabolism of a beta blocking drug, oxprenolol. , 1971, The Journal of pharmacology and experimental therapeutics.

[3]  K. Hostetler,et al.  An improved two dimensional thin-layer chromatography system for the separation of phosphatidylglycerol and its derivatives. , 1976, Journal of lipid research.

[4]  O. Wassermann,et al.  NMR-studies on the molecular basis of drug-induced phospholipidosis--II. Interaction between several amphiphilic drugs and phospholipids. , 1976, Biochemical pharmacology.

[5]  R. Jain,et al.  Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man. , 1978, The American journal of physiology.

[6]  C. George,et al.  Elimination of drugs by active intestinal transport , 1979, The Journal of pharmacy and pharmacology.

[7]  A. Wilson,et al.  Studies on the persistence of basic amines in the rabbit lung. , 1979, Drug metabolism and disposition: the biological fate of chemicals.

[8]  C. Ho,et al.  Phosphorus-31 nuclear magnetic resonance studies of human red blood cells. , 1982, Blood cells.

[9]  V. Stella,et al.  Thiamine whole blood and urinary pharmacokinetics in rats: urethan-induced dose-dependent pharmacokinetics. , 1982, Journal of pharmaceutical sciences.

[10]  Y. Sugiyama,et al.  Experimental evidence of characteristic tissue distribution of adriamycin. Tissue DNA concentration as a determinant , 1982, The Journal of pharmacy and pharmacology.

[11]  H. Mehendale,et al.  Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[12]  Ichimura Fujio,et al.  Physiological pharmacokinetic model for pentazocine. I. Tissue distribution and elimination in the rat , 1983 .

[13]  T. Iga,et al.  Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs. , 1984, Journal of pharmaceutical sciences.

[14]  R. Pownall,et al.  The absorption of β‐adrenoceptor antagonists in rat in‐situ small intestine; the effect of lipophilicity , 1985, The Journal of pharmacy and pharmacology.

[15]  W. L. Nelson,et al.  N-dealkylation of oxprenolol: formation of 3-aryloxypropane-1,2-diol, 3-aryloxylactic acid, and 2-aryloxyacetic acid metabolites in the rat. , 1985, Journal of pharmaceutical sciences.

[16]  G. Schuhmann,et al.  Prediction of drug distribution in vivo on the basis of in vitro binding data. , 1987, Biopharmaceutics & drug disposition.

[17]  T. Murakami,et al.  Role of acidic phospholipids in tissue distribution of quinidine in rats. , 1987, Journal of pharmacobio-dynamics.

[18]  D. Cutler,et al.  The potential role of lysosomes in tissue distribution of weak bases , 1988, Biopharmaceutics & drug disposition.

[19]  S. Shibasaki,et al.  Effects of cimetidine on lidocaine distribution in rats. , 1988, Journal of pharmacobio-dynamics.

[20]  J. Barré,et al.  Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution. , 1989, Progress in clinical and biological research.

[21]  E. Nakashima,et al.  Effect of fat tissue volume on the distribution kinetics of biperiden as a function of age in rats. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[22]  T. Tsuruo,et al.  Distribution of multidrug resistance-associated P-glycoprotein in normal and neoplastic human tissue , 1990 .

[23]  H Harashima,et al.  Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats. , 1990, Anesthesiology.

[24]  T. Terasaki,et al.  Physiological pharmacokinetics of a new muscle-relaxant, inaperisone, combined with its pharmacological effect on blood flow rate. , 1990, Drug Metabolism And Disposition.

[25]  D. Gole,et al.  Effects of chronic ethanol ingestion on pharmacokinetics of procainamide in rats. , 1991, Journal of pharmaceutical sciences.

[26]  B. Fichtl,et al.  Tissue Binding versus Plasma Binding of Drugs: General Principles and Pharmacokinetic Consequences , 1991 .

[27]  M E Andersen,et al.  A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat. , 1992, Toxicology and applied pharmacology.

[28]  M. Fujimaki Stereoselective disposition and tissue distribution of carvedilol enantiomers in rats. , 1992, Chirality.

[29]  R. Lefebvre,et al.  Stereoselective pharmacokinetics of oxprenolol and its glucuronides in humans , 1995, Clinical pharmacology and therapeutics.

[30]  K Krishnan,et al.  A biologically-based algorithm for predicting human tissue: blood partition coefficients of organic chemicals , 1995, Human & experimental toxicology.

[31]  Y. Sai,et al.  Active Secretion of Drugs from the Small Intestinal Epithelium in Rats by P‐Glycoprotein Functioning as an Absorption Barrier , 1996, The Journal of pharmacy and pharmacology.

[32]  S. M. Owens,et al.  Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats. , 1996, The Journal of pharmacology and experimental therapeutics.

[33]  B A Telfer,et al.  Tissue water content in rats measured by desiccation. , 1997, Journal of pharmacological and toxicological methods.

[34]  M. Piquette-Miller,et al.  PHARMACOKINETICS AND MULTIPLE PEAKING OF ACEBUTOLOL ENANTIOMERS IN RATS , 1997, Biopharmaceutics & drug disposition.

[35]  E. Nakashima,et al.  Uptake of basic drugs into rat lung granule fraction in vitro. , 1998, Biological & pharmaceutical bulletin.

[36]  F. Theil,et al.  A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. , 2000, Journal of pharmaceutical sciences.

[37]  I. Bernhardt,et al.  Variations of Intracellular pH in Human Erythrocytes via K+(Na+)/H+ Exchange Under Low Ionic Strength Conditions , 2000, The Journal of Membrane Biology.

[38]  F. Theil,et al.  Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs. , 2001, Journal of pharmaceutical sciences.

[39]  Patrick Poulin,et al.  Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. , 2002, Journal of pharmaceutical sciences.

[40]  Bradley D. Smith,et al.  Chemical control of phospholipid distribution across bilayer membranes , 2002, Medicinal research reviews.

[41]  M. Rowland,et al.  Prediction of in Vivo Tissue Distribution from in Vitro Data. 2. Correlation Between in Vitro and in Vivo Tissue Distribution of a Homologous Series of Nine 5-n-Alkyl-5-Ethyl Barbituric Acids , 2003, Pharmaceutical Research.

[42]  K. Hanada,et al.  Enantioselective Tissue Distribution of the Basic Drugs Disopyramide, Flecainide and Verapamil in Rats: Role of Plasma Protein and Tissue Phosphatidylserine Binding , 1998, Pharmaceutical Research.

[43]  T. Murakami,et al.  Phosphatidylserine as a Determinant for the Tissue Distribution of Weakly Basic Drugs in Rats , 1990, Pharmaceutical Research.

[44]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[45]  Y. Sugiyama,et al.  Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics , 1985, Journal of Pharmacokinetics and Biopharmaceutics.

[46]  K. Prasannan Influence of age on the total lipid, phospholipid and cholesterol contents of pancreas and liver of albino rats , 1973, Experientia.

[47]  Yuichi Sugiyama,et al.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals , 1984, Journal of Pharmacokinetics and Biopharmaceutics.

[48]  Malcolm Rowland,et al.  Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat. , 2005, Journal of pharmaceutical sciences.

[49]  G. Rouser,et al.  Species variations in phospholipid class distribution of organs: I. Kidney, liver and spleen , 1969, Lipids.

[50]  Ryosei Kawai,et al.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 , 1994, Journal of Pharmacokinetics and Biopharmaceutics.